Consolidation enfortumab vedotin and pembrolizumab after cisplatin induction in metastatic urothelial cancer: Outcomes of complete response and bladder preservation
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Fields of Study & Subjects
Publication details
- Journal / source
- Journal of International Medical Research
- Volume
- 54
- Issue
- 3
- Pages
- 3000605261430450–3000605261430450
- Publication date
- 1 March 2026
- Language
- EN